Finerenone
File:Finerenone.svg | |
Systematic (IUPAC) name | |
---|---|
(4S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
|
|
Clinical data | |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 1050477-31-0 |
ATC code | none |
PubChem | CID: 60150535 |
ChemSpider | 28669387 |
UNII | DE2O63YV8R |
KEGG | D10633 |
ChEMBL | CHEMBL2181927 |
Synonyms | BAY 94-8862 |
Chemical data | |
Formula | C21H22N4O3 |
Molecular mass | 378.42 g/mol |
|
|
|
Finerenone (INN, USAN) (developmental code name BAY-94-8862) is a non-steroidal antimineralocorticoid that is in phase III clinical trials for the treatment of chronic heart failure as of October 2015[update]. It has less relative affinity to other steroid hormone receptors than currently available antimineralocorticoids such as eplerenone and spironolactone, which should result in fewer adverse effects like gynaecomastia, impotence, and low sex drive.[1][2]
Pharmacology
Finerenone blocks mineralocorticoid receptors, which makes it a potassium-sparing diuretic.
This table compares inhibitory (blocking) concentrations (IC50, unit: nM) of three antimineralocorticoids. Mineralocorticoid receptor inhibition is responsible for the desired action of the drugs, whereas inhibition of the other receptors potentially leads to side effects. Lower values mean stronger inhibition.[1]
Spironolactone | Eplerenone | Finerenone | |
---|---|---|---|
Mineralocorticoid receptor | 24 | 990 | 18 |
Glucocorticoid receptor | 2400 | 22,000 | >10,000 |
Androgen receptor | 77 | 21,200 | >10,000 |
Progesterone receptor | 740 | 31,200 | >10,000 |
The above-listed drugs have insignificant affinity for the estrogen receptor.
Chemistry
Unlike currently marketed antimineralocorticoids, finerenone is not a steroid but a dihydropyridine derivative.
Research
The drug is also being investigated in early trials for the treatment of diabetic nephropathy.[3]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
- Pages with reference errors
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Articles containing potentially dated statements from October 2015
- Aldosterone antagonists
- Carboxamides
- Dihydropyridines
- Cardiovascular system drug stubs
- Articles with German-language external links